Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales
FDA Law Blog
DECEMBER 4, 2023
The Consent Agreement permanently restrained and enjoined the Defendants from administering, dispensing, or distributing: Any controlled substance earlier than two days prior to completion of the intended duration of the previous fill; Concurrent opioid and gabapentin medications unless approved by the same prescriber and the pharmacy has a documented (..)
Let's personalize your content